Skip to main content
L&C BIO Co., Ltd logo

L&C BIO Co., Ltd — Investor Relations & Filings

Ticker · 290650 ISIN · KR7290650001 KO Manufacturing
Filings indexed 378 across all filing types
Latest filing 2023-08-24 Regulatory Filings
Country KR South Korea
Listing KO 290650

About L&C BIO Co., Ltd

http://www.lncbio.co.kr/?locale=en_US

L&C BIO Co., Ltd. is a biotechnology company specializing in regenerative medicine. The company develops, manufactures, and commercializes human tissue-based medical devices and allograft treatment materials. Its core operations include the processing, storage, and distribution of human tissues, with a focus on skin, musculoskeletal, and soft tissues, utilizing patented processing technologies. The company's product portfolio also extends to other medical devices and cosmetics. L&C BIO supports its activities through dedicated research and development centers and manufacturing facilities, including a human tissue plant and a pharmaceutical plant, to advance its pipeline and serve global markets.

Recent filings

Filing Released Lang Actions
기타경영사항(자율공시)(MegaShield®-SP (메가쉴드®-SP)의 척추 수술 후 유착 방지 효과 및 안전성에 대한 임상시험계획(IND) 승인)
Regulatory Filings Classification · 100% confidence The document is a regulatory disclosure (voluntary disclosure) from L&C Bio regarding the approval of an Investigational Device Exemption (IDE/IND) for a clinical trial of their medical device, MegaShield-SP. This type of announcement regarding regulatory approvals for clinical trials or business operations that do not fit into specific financial reporting categories is classified as a general regulatory filing.
2023-08-24 Korean
반기보고서 (2023.06)
Interim / Quarterly Report Classification · 100% confidence The document is a '반기보고서' (Semi-annual Report) for L&C BIO Co., Ltd. for the period ending June 30, 2023. It contains comprehensive financial statements, management discussion and analysis, and corporate governance information, which aligns with the definition of an Interim/Quarterly Report (IR). H1 2023
2023-08-14 Korean
주요사항보고서(타법인주식및출자증권양도결정)
M&A Activity Classification · 100% confidence The document is a 'Major Report' (주요사항보고서) filed with the Financial Supervisory Service/Korea Exchange regarding the decision to dispose of shares in another corporation (타법인 주식 및 출자증권 양도결정). This is a specific regulatory disclosure requirement for material corporate events in the Korean market. Since it details a specific corporate transaction (asset disposal/divestment) and does not fit into the other specific categories like M&A or share issuance, it is classified as a Regulatory Filing (RNS).
2023-07-25 Korean
합병등종료보고서(자산양수도)
M&A Activity Classification · 100% confidence The document is a 'Report on the Completion of Merger, etc.' (합병등종료보고서) filed with the Financial Supervisory Service (FSS) in South Korea. It details the completion of an asset transfer (specifically the sale of shares in CUREXO, Inc.) by L&C Bio. Since this document reports the finalization of a corporate transaction (M&A/Asset Transfer) rather than just an announcement of a report, it falls under the M&A Activity category.
2023-07-25 Korean
전환가액의조정
Capital/Financing Update Classification · 100% confidence The document is a formal regulatory filing from L&C Bio regarding the adjustment of the conversion price for convertible bonds (CB). It details the change in conversion price, the number of shares affected, the calculation methodology based on market price, and the effective date. This type of disclosure is a standard corporate action related to capital structure and financing instruments, which falls under the 'Capital/Financing Update' category.
2023-06-29 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details changes in share ownership by a major shareholder (Lee Whan-chul) and special related parties, including changes in collateral agreements and exchangeable bond conversions. This falls under the category of Major Shareholding Notification.
2023-06-29 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.